Nicholas Donoghoe, SVP, Enterprise Innovation at AbbVie Inc. (ABBV), bought 15,050 shares at $66.19 ($996K) on 2019-08-29, disclosed to the SEC on 2019-08-30.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $66.19 | 7,525 | $498K | 50.0% |
| 2 | $66.19 | 7,525 | $498K | 50.0% |
| Total | $66.19 avg | 15,050 | $996K | 100% |
| Filing → |
| ABBV | SELL | 2024-03-22 | $7.4M | — | Filing → |
| ABBV | SELL | 2023-12-28 | $901K | — | Filing → |